Cointime

Omnix Medical

company

About

Omnix Medical develope and commercialize highly effective antibiotic agents against resistant pathogenic bacterial strains.

  • 1 - 10

Highlights

Total Funding Amount
€10.80M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
€10.80M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technology will tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€10.80M
Omnix Medical has raised a total of €10.80M in funding over 2 rounds. Their latest funding was raised on Aug 31, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 31, 2021 Grant — 1 National Institutes of Health — Detail
Jan 25, 2021 Grant €10.80M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Omnix Medical is funded by 2 investors. National Institutes of Health and European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท